Introducing PharmAlliance International Labs’ Losartan Potassium Tablets

Company Introduction:

PharmAlliance International Labs Private Limited welcomes you to a realm of excellence in healthcare, where quality meets innovation to enhance lives worldwide. We take immense pride in unveiling our latest breakthrough: Losartan Potassium Tablets, meticulously crafted to effectively combat hypertension and bolster cardiovascular health.

Drug Classification:

Losartan Potassium belongs to the esteemed class of medications known as angiotensin II receptor blockers (ARBs). Renowned for their efficacy, ARBs operate by thwarting the action of angiotensin II, a pivotal hormone that orchestrates blood vessel constriction. By inducing vasodilation and lowering blood pressure, Losartan Potassium Tablets exemplify the pinnacle of cardiovascular care.

Formulations:

Our Losartan Potassium Tablets are available in two potencies: 25mg and 50mg, encapsulating precision and potency in convenient oral tablets. Each blister pack contains 20 tablets, meticulously designed for seamless integration into your daily routine.

Indications:

Losartan Potassium Tablets are indicated for a spectrum of conditions, including:

Treatment of hypertension in adults and pediatric patients aged 6 years and older, heralding a new era in blood pressure management.

Reduction of stroke risk in hypertensive patients with left ventricular hypertrophy, underscoring our commitment to comprehensive cardiovascular care.

Management of diabetic nephropathy in individuals with type 2 diabetes and hypertension, addressing multifaceted health challenges with efficacy and precision.

Usage:

Optimal therapeutic outcomes hinge on strict adherence to the prescribed dosage and administration regimen. Losartan Potassium Tablets should be taken orally once daily, with or without food, as directed by a healthcare professional.

Dosage:

For most adults with hypertension, the recommended starting dose is 50mg once daily, with individual adjustments based on response and tolerability. Pediatric dosing is tailored to the child’s body weight and unique requirements, ensuring personalized care for every patient.

Pharmacokinetics:

Losartan boasts rapid absorption post-oral administration, culminating in peak plasma concentrations within 1 to 2 hours. Following hepatic metabolism, it transforms into its active metabolite, losartan carboxylic acid, heralding sustained antihypertensive effects.

Pharmacodynamics:

Distinguished by its selective blockade of the angiotensin II receptor subtype AT1, Losartan Potassium Tablets epitomize precision in hypertension management. By dismantling the renin-angiotensin-aldosterone system (RAAS), they foster vasodilation, mitigate blood pressure, and shield against target organ damage.

Side Effects:

While generally well-tolerated, common side effects such as dizziness, headache, and fatigue may manifest. Vigilance is paramount, as rare but serious adverse effects like hyperkalemia, hypotension, and renal impairment necessitate prompt medical attention.

Experience the unparalleled efficacy and safety of PharmAlliance International Labs’ Losartan Potassium Tablets in the quest for optimal cardiovascular health. For inquiries or further information, please don’t hesitate to contact us. Your well-being is our unwavering commitment, and we stand ready to support your journey towards a healthier, happier life.